Melatonin

Generic Name
Melatonin
Brand Names
Circadin, Slenyto, Melatonin Neurim
Drug Type
Small Molecule
Chemical Formula
C13H16N2O2
CAS Number
73-31-4
Unique Ingredient Identifier
JL5DK93RCL
Background

Melatonin is a biogenic amine that is found in animals, plants and microbes. Aaron B. Lerner of Yale University is credited for naming the hormone and for defining its chemical structure in 1958. In mammals, melatonin is produced by the pineal gland. The pineal gland is small endocrine gland, about the size of a rice grain and shaped like a pine cone (hence ...

Indication

Used orally for jet lag, insomnia, shift-work disorder, circadian rhythm disorders in the blind (evidence for efficacy), and benzodiazepine and nicotine withdrawal. Evidence indicates that melatonin is likely effective for treating circadian rhythm sleep disorders in blind children and adults. It has received FDA orphan drug status as an oral medication for ...

Associated Conditions
Insomnia
Associated Therapies
-

Comparing Treatment With Melatonin to Treatment With Stimulants (Methylphenidate) in Children With Attention Deficit Hyperactivity Disorder and Sleep Difficulties

First Posted Date
2011-07-13
Last Posted Date
2011-07-13
Lead Sponsor
Assaf-Harofeh Medical Center
Target Recruit Count
46
Registration Number
NCT01393574
Locations
🇮🇱

Assaf Haroffeh Medical Center, Zeriffin, Israel

Melatonin Treatment for Tardive Dyskinesia in Schizophrenia

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2011-07-12
Last Posted Date
2016-07-12
Lead Sponsor
Beijing HuiLongGuan Hospital
Target Recruit Count
120
Registration Number
NCT01391390
Locations
🇨🇳

Beijing HuiLongGuan hospital, Beijing, China

Melatonin Versus Placebo in the Lennox-Gastaut Syndrome: Neurophysiological and Neuropsychological Effects

Phase 4
Withdrawn
Conditions
Interventions
First Posted Date
2011-06-10
Last Posted Date
2022-07-14
Lead Sponsor
Institution de Lavigny
Registration Number
NCT01370486
Locations
🇨🇭

Institution de Lavigny, Lavigny, Vaud, Switzerland

Study With Amitriptylin to Evaluate the Efficacy of Melatonin in Treatment of Migraine

Phase 3
Completed
Conditions
Interventions
First Posted Date
2011-05-20
Last Posted Date
2015-12-30
Lead Sponsor
Hospital Israelita Albert Einstein
Target Recruit Count
192
Registration Number
NCT01357031
Locations
🇧🇷

Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil

Melatonin in Relapsing-Remitting Multiple Sclerosis Patients

Phase 2
Completed
Conditions
Interventions
First Posted Date
2011-01-19
Last Posted Date
2015-08-14
Lead Sponsor
Tehran University of Medical Sciences
Target Recruit Count
25
Registration Number
NCT01279876
Locations
🇮🇷

Iranian Center for Neurological Researches, Imam Khomeini Hospital, Tehran, Iran, Islamic Republic of

Evaluation of Anxiolysis and Pain Associated With Retrobulbar Eye Block for Cataract Surgery : Melatonin Versus Gabapentin

Phase 1
Completed
Conditions
Interventions
First Posted Date
2010-09-13
Last Posted Date
2012-10-11
Lead Sponsor
Qazvin University Of Medical Sciences
Target Recruit Count
90
Registration Number
NCT01200641
Locations
🇮🇷

Qazvin university of medical science, Qazvin, Iran, Islamic Republic of

Melatonin and Nighttime Blood Pressure in African Americans-8 mg Study

Phase 2
Completed
Conditions
Interventions
First Posted Date
2010-05-03
Last Posted Date
2015-12-18
Lead Sponsor
Emory University
Target Recruit Count
37
Registration Number
NCT01114360
Locations
🇺🇸

Emory University, Atlanta, Georgia, United States

Melatonin and Nighttime Blood Pressure in African Americans--24 mg Study

Phase 2
Completed
Conditions
Interventions
First Posted Date
2010-05-03
Last Posted Date
2016-02-26
Lead Sponsor
Emory University
Target Recruit Count
40
Registration Number
NCT01114373
Locations
🇺🇸

Emory University, Atlanta, Georgia, United States

Antiinflammatoric and Antioxidative Effect of Melatonin in Human Endotoxaemia

Phase 4
Completed
Conditions
Interventions
First Posted Date
2010-03-16
Last Posted Date
2011-06-20
Lead Sponsor
Herlev Hospital
Target Recruit Count
12
Registration Number
NCT01087359
Locations
🇩🇰

Herlev Hospital, Herlev, Denmark

Melatonin and the Metabolic Syndrome

Phase 2
Completed
Conditions
Interventions
First Posted Date
2009-12-24
Last Posted Date
2015-02-27
Lead Sponsor
Emory University
Target Recruit Count
39
Registration Number
NCT01038921
Locations
🇺🇸

Emory University, Atlanta, Georgia, United States

🇺🇸

Emory Hospital, Atlanta, Georgia, United States

© Copyright 2024. All Rights Reserved by MedPath